Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2003

01-03-2003

Increased Expression of BRCA1 mRNA Predicts Favorable Response to Anthracycline-Containing Chemotherapy in Breast Cancers

Authors: Chiyomi Egawa, Kazuyoshi Motomura, Yasuo Miyoshi, Yuuki Takamura, Tetsuya Taguchi, Yasuhiro Tamaki, Hideo Inaji, Hiroki Koyama, Shinzaburo Noguchi

Published in: Breast Cancer Research and Treatment | Issue 1/2003

Login to get access
Metadata
Title
Increased Expression of BRCA1 mRNA Predicts Favorable Response to Anthracycline-Containing Chemotherapy in Breast Cancers
Authors
Chiyomi Egawa
Kazuyoshi Motomura
Yasuo Miyoshi
Yuuki Takamura
Tetsuya Taguchi
Yasuhiro Tamaki
Hideo Inaji
Hiroki Koyama
Shinzaburo Noguchi
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1022101310500

Other articles of this Issue 1/2003

Breast Cancer Research and Treatment 1/2003 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine